The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism

M. Kawamura, Shuichi Ohara, T. Koike, K. Iijima, Jin Suzuki, S. Kayaba, Kenji Noguchi, S. Hamada, Mitsunori Noguchi, T. Shimosegawa

Research output: Contribution to journalArticlepeer-review

102 Citations (Scopus)

Abstract

Background: The acid suppressive effect of lansoprazole is influenced by the P450 2C19 (CYP2C19) polymorphism. Aim: To investigate whether the CYP2C19 genotype is related to the healing of erosive reflux oesophagitis during treatment with lansoprazole. Methods: Eighty-eight Japanese patients with erosive reflux oesophagitis were treated with a daily oral dose of 30 mg lansoprazole for 8 weeks. The CYP2C19 genotype, Helicobacter pylori infection status and serum pepsinogen I/II ratio were assessed before treatment. At 4 and 8 weeks, the healing of erosive reflux oesophagitis was evaluated endoscopically. Results: The healing rates were 57.1%, 69.2% and 72.7% at 4 weeks and 77.4%, 95.0% and 100% at 8 weeks in homozygous extensive metabolizers, heterozygous extensive metabolizers and poor metabolizers, respectively. At 8 weeks, the healing rate of erosive reflux oesophagitis was significantly lower in homozygous extensive metabolizers than in the other two groups (P < 0.05). The H. pylori status and serum pepsinogen I/II ratio had less influence than CYP2C19 polymorphism on the healing rate of erosive reflux oesophagitis. Conclusions: The therapeutic effect of lansoprazole on erosive reflux oesophagitis is influenced by the CYP2C19 genotype status. Therefore, a test of CYP2C19 genotype may be useful for the medical treatment of reflux oesophagitis with lansoprazole.

Original languageEnglish
Pages (from-to)965-973
Number of pages9
JournalAlimentary Pharmacology and Therapeutics
Volume17
Issue number7
DOIs
Publication statusPublished - 2003 Apr 1

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism'. Together they form a unique fingerprint.

Cite this